Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma

Thorax

Volumn 52, Issue 10, 1997, Pages 853-860

  Wisniewski, Antoni F ^a   Lewis, Sarah A ^a   Green, Des J ^a   Maslanka, Wendy ^a   Burrell, Helen ^a   Tattersfield, Anne E ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Bone metabolism; Bone mineral density; Inhaled steroids

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID; DEOXYPYRIDINOLINE; OSTEOCALCIN; PROCOLLAGEN;

ADULT; ARTICLE; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; VERTEBRA FRACTURE;

EID: 0030836313     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.10.853     Document Type: Article

References (40)

1. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G. Corticosteroids and bone mass in asthma: comparison with rheumatoid arthritis and polymyalgia rheumatica. BMJ 1986;293:1463-6.
2. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Mcd 1983; 309:265-8.
3. Luengo M, Picado C, Del Rio L, Guanabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study (see comments). Thorax 1991;46:803-6.
4. Packe GE, Douglas JG, McDonald AF, Robins SP, Reid DM. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992;47:414-7.
5. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 1994;105:1722-7.
6. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995;96:571-9.
7. Boulet LP, Giguere MC, Milot J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994;94: 796-803.
8. Wolff AH, Adelsberg B, Aloia J, Zitt M. Effect of inhaled corticosteroids on bone density in asthmatic patients: a pilot study. Ann Allergy 1991;67:117-21.
9. Toogood JH, Baskerville JC, Markov AE, Hodsman AB, Fraher LJ, Jennings B, et al. Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol 1995; 96:157-66.
10. Konig P, Hillman L, Cervantes C, Levine C, Maloney C, Douglas B, et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 1995;122:219 26.
11. Baraldi E, Bollini MC, De Marchi A, Zacchello F. Effect of beclomethasone dipropionate on bone mineral content assessed by x-ray densitometry in asthmatic children: a longitudinal evaluation. Ear Respir J 1994;7:710-4.
12. Martinati LC, Bertoldo F, Gasperi E, Micelli S, Boner AL. Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med 1996; 153:232-6.
13. Kinberg KA, Hopp RJ, Biven RU, Gallagher JC. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol 1994;94:490-7.
14. Leech JA, Hodder RV, Ooi DS, Gay J. Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis 1993;148:113-5.
15. Teelucksingh S, Padfield PL, Tibi L, Gough KJ, Holt PR. Inhaled corticosteroids, bone formation and osteocalcin. Lancet 1991;338:60-1.
16. Pouw EM, Prummel MF, Oosting H, Roos CM, Enden E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 1991;302:627-8.
17. Meeran K, Hattersley A, Burrin J, Shiner R, Ibbertson K. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care Med 1995;151:333-6.
18. Kerstjens HAM, Postma DS, van Doormaal JJ, van Zanten AK, Brand PLP, Dekhuijzen PNR, et al. Effects of short term and long term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Thorax 1994;49:652-6.
19. Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991;46: 160 4.
20. Jennings BH, Andersson K-E, Johansson S-A. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991;40:77-82.
21. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986;61:1049-55.
22. Carter DR, Orr TE. Skeletal development and bone functional adaptation. J Bone Mineral Res 1992;7(Suppl 2): S389-95.
23. Dalsky GP. Exercise: its effect on bone mineral content. Clin Obstet Gynecol 1987;30:820-32.
24. Gibson PG, Henry RL, Vimpani GV, Halliday J. Asthma knowledge, attitudes, and quality of life in adolescents. Arch Dis Child 1995;73:321-6.
25. Quanjer PH. Standardised lung function testing. Bull Eur Physiopathol Respir 1983;19(Suppl 5):1-95.
26. Eastell R, Cedel SL, Wahner HW, Riggs BL, Mellon LJ. Classification of vertebral fractures. J Bone Mineral Res 1991;6:207-15.
27. Sowers MF, Galuska DA. Epidemiology of bone mass in premenopausal women. Epidemiol Rev 1993;15:374-98.
28. Rosenthal DI, Mayo-Smith W, Hayes CW, Khurana JS, Biller BM, Neer RM, et al. Age and bone mass in premenopausal women. J Bone Mineral Res 1989;4:533-8.
29. Pocock NA, Eisman JA, Dunstan CR, Evans RA, Thomas DH, Huq NL. Recovery from steroid-induced osteoporosis. Ann Intern Med 1987;107:319-23.
30. Rizzato G, Montemurro L. Reversibility of exogenous corticosteroid-induced bone loss. Eur Respir J 1993;6: 116-9.
31. James VHT, Munro DD, Feiwel M. Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate. Lancet 1967;1059-61.
32. Munro DD, Wilson L. Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy. BMJ 1975;3:626-8.
33. Bassey EJ, Ramsdale SJ, Pye DW. Impact exercise and femoral bone mineral density. Curr Rev Osteoporosis Bone Mineral Measurement 1994;III:88.
34. Sowers MR, Clark MK, Hollis B, Wallace RB, Jannausch M. Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Mineral Res 1992;7:647 57.
35. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Laboratory Sci 1991; 28:287-335.
36. Marshall DH, Crilly R, Nordin BE. The relation between plasma androstenedume and oestrone levels in untreated and corticosteroid-treated post-menopausal women. Clin Endocrinol 1978;9:407 12.
37. Christiansen C, Riis HJ, Nilas L, Rodbro P, Deftos L. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in post-menopausal osteoporosis. Lancet 1985;ii:800 1.
38. Wasnich R. Bone mass measurement: prediction of risk. Am J Med 1993;95(Suppl 5A):6s 10s.
39. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A logitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983; 25:615 20.
40. Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Poeock N, et al. Corticosteroid effects on proximal femur hone loss. J Bone Mineral Res 1990;5:1211-6.